Synthesis, characterization of benzimidazole carboxamide derivatives as potent anaplastic lymphoma kinase inhibitor and antioxidant activity

References

• Plummer, M.; de Martel, C.; Vignat, J.; Ferlay, J.; Bray, F.; Franceschi, S. Global Burden of Cancers Attributable to Infections in 2012: A Synthetic Analysis. The Lan. Glob. Health. 2016, 4, 609-616.
   PubMed Web of Science ®Google Scholar
• Torre, L. A.; Bray, F.; Siegel, R. L.; Ferlay, J.; Tieulent, J. L.; Jemal, A. Global Cancer Statistics, 2012. CA Cancer J. Clin. 2015, 65, 87-108.
   PubMed Web of Science ®Google Scholar
• Chen, W.; Zheng, R.; Baade, P. D.; Zhang, S.; Zeng, H.; Bray, F.; Jemal, A.; Yu, X. Q.; He, J. Cancer Statistics in China, 2015. CA Cancer J. Clin. 2016, 66, 115-132.
   PubMed Web of Science ®Google Scholar
• Starok, M.; Preira, P.; Vayssade, M.; Haupt, K.; Salome, L.; Rossi, C. EGFR Inhibition by Curcumin in Cancer Cells: A Dual Mode of Action. Biomacromolecules. 2015, 16, 1634-1642.
   PubMed Web of Science ®Google Scholar
• Passerini, C. G.; Messa, C.; Pogliani, E. Crizotinib in Anaplastic Large-Cell Lymphoma. N. Engl. J. Med. 2011, 364, 775-776.
   PubMed Web of Science ®Google Scholar
• Fukuhara, S.; Nomoto, J.; Kim, S. W.; Taniguchi, H.; Maeshima, A. M.; Tobinai, K.; Kobayashi, Y. Partial Deletion of the ALK Gene in ALK‐positive Anaplastic Large Cell Lymphoma. Hemat. Oncol. 2018, 36, 1-378.
   Web of Science ®Google Scholar
• Soda, M.; Choi, Y. L.; Enomoto, M.; Takada, S.; Yamashita, Y.; Ishikawa, S.; Fujiwara, S-i.; Watanabe, H.; Kurashina, K.; Hatanaka, H.; et al. Identification of the Transforming EML4-ALK Fusion Gene in Non-small-cell Lung Cancer. Nature. 2007, 448, 561-566.
   PubMed Web of Science ®Google Scholar
• Rikova, K.; Guo, A.; Zeng, Q. Global Surv. Phosphotyrosine Signal. Identifies Onco. Kinases in Lung Canc. Cel. 2007, 131, 1190-1203.
   Google Scholar
• Camidge, D. R.; Doebele, R. C. Treating ALK-Positive Lung Cancer-early Successes and Future Challenges. Nat. Rev. Clin. Oncol. 2012, 9, 268-277.
   PubMed Web of Science ®Google Scholar
• Blackhall, F. H.; Peters, S.; Kerr, K. M. Prevalence and Clinical Outcomes for Patients with ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project. Ann. Oncol. 2012, 23, 73-94.
   Web of Science ®Google Scholar
• Sharma, G. V. M.; Ramesh, A.; Singh, A.; Srikanth, G.; Jayaram, V.; Duscharla, D.; Jun, J. H.; Ummanni, R.; Malhotra, S. V. Imidazole Derivatives Show Anticancer Potential by Inducing Apoptosis and Cellular Senescence. Med. Chem. Commun. 2014, 5, 1751-1760.
   Google Scholar
• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2016. CA Canc. J. Clin. 2016, 66, 7-30.
   PubMed Web of Science ®Google Scholar
• Ou, S.-H. I.; Kwak, E. L.; Siwak-Tapp, C.; Dy, J.; Bergethon, K.; Clark, J. W.; Camidge, D. R.; Solomon, B. J.; Maki, R. G.; Bang, Y.-J.; et al. Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification. J. Thorac. Oncol. 2011, 6, 942-946.
   PubMed Web of Science ®Google Scholar
• Bergethon, K.; Shaw, A. T.; Ou, S. H. Targeting ROS1 with Anaplastic Lymphoma Kinase Inhibitors: A Promising Therapeutic Strategy for a Newly Defined Molecular Subset of Non-Small-Cell Lung Cancer. J. Clin. Oncol. 2012, 30, 4449-4457.
   PubMedGoogle Scholar
• Cui, J. J.; Tran-Dube, M.; Shen, H.; Nambu, M.; Kung, P.; Pairish, M.; Jia, L.; Meng, J.; Funk, L.; Botrous, I.; et al. Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK). J. Med. Chem. 2011, 54, 6342-6363.
   PubMed Web of Science ®Google Scholar
• Lakshmanan, S.; Ramalakshmi, N. One-Pot, Four-Component Synthesis of Benzylpyrazolyl Naphthoquinone Derivatives and Molecular Docking Studies. Synth. Commun. 2016, 46, 2045.
   Web of Science ®Google Scholar
• Hallberg, B.; Palmer, R. H. Crizotinib-Latest Champion in the Cancer Wars. N. Engl. J. Med 2010, 363, 1760-1762.
   PubMed Web of Science ®Google Scholar
• McKellar, Q. A.; Scott, E. W. The Benzimidazole Anthelmintic Agents-A Review. J. Vet. Pharmacol. Ther. 1990, 13, 223-247.
   PubMed Web of Science ®Google Scholar
• Starcevic, K.; Kralj, M.; Ester, K.; Sabol, I.; Grce, M.; Pavelic, K.; Kraminski-Zamola, G. Synthesis, Antiviral and Antitumor Activity of 2-Substituted-5-Amidino-Benzimidazoles. Bioorg. Med. Chem. 2007, 15, 4419-4426.
   PubMed Web of Science ®Google Scholar
• Serafin, B.; Borkowska, G.; Główczyk, J.; Kowalska, I.; Rump, S. Potential Antihypertensive Benzimidazole Derivatives. Pol. J. pharmacol. Pharm. 1989, 41, 89-96.
   PubMedGoogle Scholar
• Wang, X. J.; Xi, M. Y.; Fu, J. H.; Zhang, F. R.; Cheng, G. F.; Yin, D. L.; You, Q. D. Synthesis, Biological Evaluation and SAR Studies of Benzimidazole Derivatives as H1-antihistamine Agents. Chin. Chem. Lett. 2012, 23, 707-710.
   Web of Science ®Google Scholar
• Desai, N. C.; Shihory, N. R.; Kotadiya, G. M.; Desai, P. Synthesis, antibacterial and Antitubercular Activities of Benzimidazole Bearing Substituted 2-Pyridone Motifs. Euro. J. Med. Chem. 2014, 23, 480-489.
   Google Scholar
• Menteşe, E.; Yılmaz, F.; Baltaş, N.; Bekircan, O.; Kahveci, B. Synthesis and Antioxidant Activities of Some New Triheterocyclic Compounds Containing Benzimidazole, Thiophene, and 1,2,4-Triazole Rings. J. Enz. Inhi. Medi. Chem. 2015, 30, 435-441.
   PubMed Web of Science ®Google Scholar
• Ates-Alagoz, Z.; Can-Eke, B.; Coban, T.; Iscan, M.; Buyukbingol, E. Antioxidant Properties of Novel Benzimidazole Retinoids. Arch. Pharm. (Weinheim) 2004, 337, 188-192.
   PubMed Web of Science ®Google Scholar
• Clarke, G.; Nee Ting, K.; Wiart, C.; Fry, J. High Correlation of 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) Radical Scavenging, Ferric Reducing Activity Potential and Total Phenolics Content Indicates Redundancy in Use of All Three Assays to Screen for Antioxidant Activity of Extracts of Plants from the Malaysian Rainforest. Antioxidants. 2013, 2, 10.
   Google Scholar
• Matsuno, K.; Yamazaki, H.; Isaka, Y.; Takai, K.; Unno, Y.; Ogo, N.; Ishikawa, Y.; Fujii, S.; Takikawa, O.; Asai, A. Novel Candesartan Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors. Med. Chem. Commun. 2012, 3, 475-479.
   Google Scholar
• Barbuceanu, S. F.; Ilies, D. C.; Saramet, G.; Uivarosi, V.; Draghici, C.; Radulescu, V. Synthesis and Antioxidant Activity Evaluation of New Compounds from Hydrazinecarbothioamide and 1,2,4-Triazole Class Containing Diarylsulfone and 2,4-Difluorophenyl Moieties. Ijms. 2014, 15, 10908-10925.
   Google Scholar
• Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, T.; Kudin, K. N.; Gaussian, B. J. C. Gaussian 03, Revision C.01; Gaussian, Inc.: Wallingford, CT, USA, 2004; Vol. 01.
   Google Scholar
• Sebastian, S. H. R.; Al-Alshaikh, M. A.; El-Emam, A. A.; Panicker, C. Y.; Zitko, J.; Dolezal, M.; Alsenoy, C. V. Spectroscopic, Quantum Chemical Studies, Fukui Functions, in Vitro Antiviral Activity and Molecular Docking of 5-chloro-N-(3-nitrophenyl)pyrazine-2-Carboxamide. J. Mol. Struct. 2016, 1119, 188-199.
   Web of Science ®Google Scholar
• Ali, A.; Asif, M.; Alam, P.; Alam, M. J.; Sherwani, M. A.; Khan, R. H.; Ahmad, S. Shamsuzzaman, DFT/B3LYP Calculations, in Vitro Cytotoxicity and Antioxidant Activities of Steroidal Pyrimidines and Their Interaction with HSA Using Molecular Docking and Multispectroscopic Techniques. Bioorg. Chem. 2017, 73, 83-99.
   PubMed Web of Science ®Google Scholar
• Bavadi, M.; Niknam, K.; Shahraki, O. Novel Pyrrole Derivatives Bearing Sulfonamide Groups: Synthesis in Vitro Cytotoxicity Evaluation, molecular Docking and DFT Study. J. Mol. Struct. 2017, 1146, 242-253.
   Web of Science ®Google Scholar
• Kavitha, T.; Velraj, G. Density Functional Theory Analysis and Molecular Docking Evaluation of 1-(2, 5-dichloro-4-sulfophenyl)-3-Methyl-5-Pyrazolone as COX2 Inhibitor against Inflammatory Diseases. J. Mol. Struct. 2017, 1141, 335-345.
   Web of Science ®Google Scholar
• Lakshmanan, S.; Govindaraj, D.; Ramalakshmi, N.; Arul Antony, S. Synthesis, Molecular Docking, DFT Calculations and Cytotoxicity Activity of Benzo[g]quinazoline Derivatives in Choline Chloride-Urea. J. Mol. Struct. 2017, 1150, 88-95.
   Web of Science ®Google Scholar
• Thirumurugan, K.; Lakshmanan, S.; Govindaraj, D.; Daniel Prabu, D. S.; Ramalakshmi, N.; Arul Antony, S. Design, Synthesis and Anti-inflammatory Activity of Pyrimidine Scaffold Benzamide Derivatives as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. J. Mol. Struct. 2018, 1171, 541-550.
   Web of Science ®Google Scholar
• Okulik, N.; Jubert, A. H. Theoretical Analysis of the Reactive Sites of Non-steroidal Anti-Inflammatory Drugs. Int. Elect. J. Mol. Des. 2005, 4, 17-30.
   Google Scholar
• Oyedemi, S. O.; folayan, A. J. Antibacterial and antioxidant activities of hydroalcoholic stem bark extract of Schotia latifolia Jacq. Asian Pacific Journal of Tropical Medicine. 2011, 4, 952-958.
   PubMedGoogle Scholar